European court upholds 10x patent after Nanostring appealed injunction

New hope for 10x’ preliminary injunction after EPO Opposition Division ruling | Patent at issue concerns single-cell spatial molecular imaging products.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

10x Genomics counsel: ‘Winning cases is a top priority’

22 October 2024 10x Genomics senior director of IP and litigation shares her team's tasks, how she’s handling UPC litigation, and why sometimes she wants a ‘gut answer’ from externals, finds Marisa Woutersen.

Europe

NanoString buyer claims ‘win for science’ as German court invalidates 10x patent

9 May 2024 Biotech firm to ask Munich court to permanently lift injunction on CosMx products following ruling | Judgment comes a day after acquisition by Bruker was finalised.

Biotechnology

UPC Court of Appeal revokes NanoString injunction in first substantive decision

27 February 2024 UPC overturns previous decision barring NanoString from selling CosMx products in 17 European countries | Court did not stay proceedings on account of NanoString’s Chapter 11 filing.

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

European court upholds 10x patent after Nanostring appealed injunction

More on this story

Editor's picks

Editor's picks

More features